Click image to zoom

Daily Life During The Coronavirus Pandemic In Ontario

Sign at a pharmacy informing people to join the waitlist to receive the AstraZeneca / COVISHIELD novel coronavirus (COVID-19) vaccine in Markham, Ontario, Canada on April 15, 2021. The AstraZeneca COVID‐19 Vaccine (manufactured by AstraZeneca) and COVISHIELD (manufactured by Serum Institute of India) has been plagued with bad press after recent studies confirmed that the Oxford-AstraZeneca vaccine may cause very rare blood clots. Health Canada has insured the shot is safe and reiterated that the benefits of getting the shot outweigh the risks. This comes as a Quebec woman was reported to be the first in Canada to develop a blood clot after being vaccinated with the Oxford-AstraZeneca vaccine. (Photo by Creative Touch Imaging Ltd./NurPhoto)

Photo Details

Photo ID	#6622236
Date Taken	14 April 2021
Location	N/A
Photographer	Creative Touch Imaging Ltd/NurPhoto
Category	Health
Copyright	© 2026 NurPhoto - Creative Touch Imaging Ltd/NurPhoto

Related Keywords

virus infection outbreak pandemic viral infection coronavirus novel coronavirus corona virus new coronavirus presumptive Toronto Ontario Canada China North America Wuhan health infection viral infection health risk healthcare precaution precautions fear precautionary measures epidemic Chinese virus Chinese 2019-nCoV 2019 nCoV contagion SARS coronaviruses infectious diseases infectious disease infectious disease panic precaution news world news viral nCoV2020 nCoV 2020 2020 nCoV COVID-19 Coronavirus Disease 2019 pandemic global pandemic COVID 19 SARS-CoV-2 SARS CoV-2 SARS CoV2 SARS CoV 2 Worldwide Emergency Covid Emergency 2020 Covid Covid2020 Covid-19 Worldwide Emergency Crisis Quarantine Coronavirus Quarantine Pandemic Pandemy Covid-19 Emergency vaccination centre vaccination vaccine vaccination center York Region Markham sign York Region Oxford-AstraZeneca vaccine vaccine Oxford-AstraZeneca pharmacy AstraZeneca AstraZeneca vaccine COVISHIELD COVISHIELD vaccine

License This Photo

Digital Basic Editorial use on digital platforms only (websites, social media). Single use, up to 1 million monthly UVs. Worldwide distribution. NO COMMERCIAL OR PROMOTIONAL USE

€35.00

Editorial Print & Digital For editorial use in print and digital publications such as newspapers, magazines, and textbooks. Single use, up to 10,000 copies or 1 million UVs. Worldwide distribution. NO COMMERCIAL OR PROMOTIONAL USE

€99.00

Broadcast (TV & Digital) For editorial use in TV production or streaming platforms. Single use, all media rights excluding theatrical, with worldwide distribution in perpetuity. NO COMMERCIAL OR PROMOTIONAL USE

€399.00

Total Price

€35.00

Secure checkout

Need a custom license?

Contact Sales

[email protected]
+39 0862 1956328